Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Genetic studies have shown that the tuberous sclerosis complex (TSC) 1–TSC2–mammalian target of Rapamycin (mTOR) and the Hippo–Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1–TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cross-talk also exists between Tsc1 and Tsc2 and the Hippo effector Yap as Tsc1/2-deficient cells have higher Yap levels due to less Yap degradation via the autophagosome system (83).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 1×
“…mTORC1 inhibits the initiation of autophagy, which is a eukaryotic catabolic pathway that sequesters cellular organelles and proteins in double-membrane autophagosomes, and delivers and degrades the cargos in lysosomes (He and Klionsky, 2009; Mizushima and Komatsu, 2011; Choi et al., 2013).”
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 1×
“It is mainly through heterodimeric GTPases RagA/B and RagC/D, which were anchored to lysosomes through Ragulator protein complex (Lamtor1-5) and v-ATPase (Sancak et al., 2010; Sancak et al., 2008; Zoncu et al., 2011).”
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653 · cited 1×
“differentiate into adipocytes and smooth muscle cells in vitro, which are two major components commonly observed in angiomyolipomas (Armulik et al., 2011).”
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
“…also suggests that, in some contexts, YAP/TAZ constantly rejuvenate cancer cells by promoting basal levels of autophagy to avoid senescence (Garcia-Prat et al., 2016; Song et al., 2015a), while still opposing cell death caused by an excess of autophagy in the tumor bulk (Liang et al., 2014).”
BackgroundMechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
“In fact, ubiquitination of other Hippo pathway components has also been reported (Wang et al. 2012; Lignitto et al. 2013; Rodrigues-Campos andThompson 2014), indicating that ubiquitination is a common regulatory mechanism often resulting in degradation of the Hippo pathway components and…”
YAP/TAZ upstream signals and downstream responses
Totaro, A., Panciera, T., & Piccolo, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0142-z · Cited by 1,086
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
“In addition, the nutrient and energy sensor Target of Rapamycin (TOR) has been shown to promote Yki/YAP activity in Drosophila and mammalian cells (Liang et al., 2014; Parker and Struhl, 2015).”
BackgroundYAP and TAZ: a nexus for Hippo signaling and beyond
Hansen, C. G., Moroishi, T., & Guan, K.-L. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.05.002 · Cited by 574
The Role of Autophagy in the Heart
Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121427 · Cited by 547
The Hippo Signaling Network and Its Biological Functions
Misra, J. R., & Irvine, K. D. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031621 · Cited by 497
Interplay between YAP/TAZ and Metabolism
Koo, J. H., & Guan, K.-L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.010 · Cited by 472
Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction
Dupont, S. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.034 · Cited by 449
Aging and Autophagy in the Heart
Shirakabe, A., Ikeda, Y., Sciarretta, S., Zablocki, D. K., & Sadoshima, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.307474 · Cited by 441
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Bertero, T., Oldham, W. M., Cottrill, K. A., Pisano, S., Vanderpool, R. R., Yu, Q., Zhao, J., Tai, Y., Tang, Y., Zhang, Y.-Y., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86387 · Cited by 439
YAP/TAZ functions and their regulation at a glance
Pocaterra, A., Romani, P., & Dupont, S. (2020) · Journal of Cell Science · doi:10.1242/jcs.230425 · Cited by 367
Regulation of TEAD Transcription Factors in Cancer Biology
Huh, H., Kim, D., Jeong, H.-S., & Park, H. (2019) · Cells · doi:10.3390/cells8060600 · Cited by 259
The Role of Reactive Oxygen Species (ROS) in the Formation of Extracellular Traps (ETs) in Humans
Stoiber, W., Obermayer, A., Steinbacher, P., & Krautgartner, W.-D. (2015) · Biomolecules · doi:10.3390/biom5020702 · Cited by 249
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Pobbati, A. V., & Hong, W. (2020) · Theranostics · doi:10.7150/thno.40889 · Cited by 222
Planas-Paz, L., Sun, T., Pikiolek, M., Cochran, N. R., Bergling, S., Orsini, V., Yang, Z., Sigoillot, F., Jetzer, J., Syed, M., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.005 · Cited by 216
Hansen, C. G., Ng, Y. L. D., Lam, W.-L. M., Plouffe, S. W., & Guan, K.-L. (2015) · Cell Research · doi:10.1038/cr.2015.140 · Cited by 212
The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park, J. H., Shin, J. E., & Park, H. W. (2018) · PubMed · doi:10.14348/molcells.2018.2242 · Cited by 193
Integration of Hippo-YAP Signaling with Metabolism
Ibar, C., & Irvine, K. D. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.025 · Cited by 185
Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway
Ehmer, U., & Sage, J. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0305 · Cited by 181
Chen, Y.-A., Lu, C.-Y., Cheng, T., Pan, S., Chen, H., & Chang, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00060 · Cited by 176
Platelet-derived exosomes promote neutrophil extracellular trap formation during septic shock
Jiao, Y., Li, W., Wang, W., Tong, X., Xia, R., Fan, J., Du, J., Zhang, C., & Shi, X. (2020) · Critical Care · doi:10.1186/s13054-020-03082-3 · Cited by 165
Self-citationControl of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways
Santinon, G., Pocaterra, A., & Dupont, S. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.11.004 · Cited by 165
Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism
Ardestani, A., Lupse, B., & Maedler, K. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.04.006 · Cited by 160
Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism
Ebrahimi-Fakhari, D., Saffari, A., Wahlster, L., Lu, J., Byrne, S., Hoffmann, G. F., Jungbluth, H., & Sahin, M. (2016) · Brain · doi:10.1093/brain/awv371 · Cited by 158
Feng, Y., Liang, Y., Zhu, X., Wang, M., Gui, Y., Lu, Q., Gu, M., Xue, X., Sun, X., He, W., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005457 · Cited by 152
“7 cells with verteporfin, a Yap inhibitor (28), followed by TGF 1 or TGF 1 plus Wnt5a treatment to induce macrophage M2 polarization.”
BackgroundSelf-citationRenal disease in tuberous sclerosis complex: pathogenesis and therapy
Lam, H. C., Siroky, B. J., & Henske, E. P. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0059-6 · Cited by 144
Self-citationRozengurt, E., Sinnett-Smith, J., & Eibl, G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0005-2 · Cited by 137
Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell
Guo, M., Yu, J. J., Perl, A. T., Wikenheiser‐Brokamp, K. A., Riccetti, M., Zhang, E. Y., Sudha, P., Adam, M., Potter, A., Kopras, E. J., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201912-2445oc · Cited by 134
Self-citationMolecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Hippo Signaling Pathway in Gliomas
Masliantsev, K., Karayan, L., & Guichet, P. (2021) · Cells · doi:10.3390/cells10010184 · Cited by 130
White, S. M., Avantaggiati, M. L., Nemazanyy, I., Poto, C. D., Yang, Y., Pende, M., Gibney, G. T., Ressom, H. W., Field, J., Atkins, M. B., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.014 · Cited by 129
Self-citationGoodman, C. A., Dietz, J. M., Jacobs, B. L., McNally, R. M., You, J.-S., & Hornberger, T. A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.047 · Cited by 121
mTORC1, the maestro of cell metabolism and growth
He, L., Cho, S., & Blenis, J. (2024) · Genes & Development · doi:10.1101/gad.352084.124 · Cited by 114
Hippo signalling during development
Davis, J. R., & Tapon, N. (2019) · Development · doi:10.1242/dev.167106 · Cited by 110
A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
Yamaguchi, H., & Taouk, G. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00928 · Cited by 110
Depdc5 knockout rat: A novel model of mTORopathy
Marsan, E., Ishida, S., Schramm, A., Weckhuysen, S., Muraca, G., Lecas, S., Liang, N., Treins, C., Pende, M., Roussel, D., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.010 · Cited by 101
Self-citationInflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Lee, Y. A., & Friedman, S. L. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13380 · Cited by 108
Furth, N., Aylon, Y., & Oren, M. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.163 · Cited by 95
Artinian, N., Cloninger, C., Holmes, B., Benavides-Serrato, A., Bashir, T., & Gera, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656587 · Cited by 94
Hino, O., & Kobayashi, T. (2016) · Cancer Science · doi:10.1111/cas.13116 · Cited by 93
Emerging role of the Hippo pathway in autophagy
Wang, D., He, J., Huang, B., Liu, S., Zhu, H., & Xu, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03069-6 · Cited by 92
Li, L., Yang, S., Xu, L., Li, Y., Fu, Y., Zhang, H., & Song, J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.007 · Cited by 86
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 85
Regulation of the Hippo pathway in cancer biology
Moon, S., Park, S. Y., & Park, H. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2804-1 · Cited by 83
mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease
Feng, J., Qiu, S., Zhou, S., Tan, Y., Bai, Y., Cao, H., Guo, J., & Su, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169196 · Cited by 80
Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis
Gui, Y., Li, J., Lu, Q., Ye, F., Wang, M., He, W., Yang, J., & Dai, C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004073 · Cited by 79
Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β
Jiménez‐Uribe, A. P., Gómez‐Sierra, T., Aparicio‐Trejo, O. E., Orozco‐Ibarra, M., & Pedraza‐Chaverrí, J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110123 · Cited by 73
Song, Q., Mao, B., Cheng, J., Gao, Y., Jiang, K., Chen, J., Yuan, Z., & Meng, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120790 · Cited by 73
Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation
Grosbois, J., Devos, M., & Demeestere, I. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa020 · Cited by 73
New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
Zhao, Y., Sheldon, M., Sun, Y., & Ma, L. (2023) · Cancers · doi:10.3390/cancers15235497 · Cited by 68
Bai, Z., Tay, V., Guo, S., Ren, J., & Shu, M. (2018) · BioMed Research International · doi:10.1155/2018/6165192 · Cited by 68
Lam, H. C., Baglini, C. V., Lope, A. L., Parkhitko, A. A., Liu, H.-J., Alesi, N., Malinowska, I. A., Ebrahimi‐Fakhari, D., Saffari, A., Yu, J. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2458 · Cited by 66
Self-citationActivation of Aurora A kinase increases YAP stability via blockage of autophagy
Wang, P., Gong, Y., Guo, T., Li, M., Fang, L., Yin, S., Muhammad, K. I., Liu, Y., Xu, J., Xu, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1664-4 · Cited by 64
Claude‐Taupin, A., Isnard, P., Bagattin, A., Kuperwasser, N., Roccio, F., Ruscica, B., Goudin, N., Garfa‐Traoré, M., Regnier, A., Turinsky, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43775-1 · Cited by 63
Self-citationEmerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders
Han, J., Zhang, J., Zhang, X., Luo, W., Liu, L., Zhu, Y., Liu, Q., & Zhang, X. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04011-9 · Cited by 63
Regulation of Myocardial Cell Growth and Death by the Hippo Pathway
Ikeda, S., & Sadoshima, J. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0476 · Cited by 63
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Ardestani, A. D., & Maedler, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00167 · Cited by 60
Structural and Functional Overview of TEAD4 in Cancer Biology
Chen, M., Huang, B., Zhu, L., Chen, K., Liu, M., & Zhong, C. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s266649 · Cited by 60
Desideri, E., Castelli, S., Dorard, C., Toifl, S., Grazi, G. L., Ciriolo, M. R., & Baccarini, M. (2022) · Autophagy · doi:10.1080/15548627.2022.2063004 · Cited by 59
YAP in pancreatic cancer: oncogenic role and therapeutic strategy
Mao, W., Mai, J., Peng, H., Wan, J., & Sun, T. (2020) · Theranostics · doi:10.7150/thno.53438 · Cited by 59
YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases
Ikeda, S., Nah, J., Shirakabe, A., Zhai, P., Oka, S., Sciarretta, S., Guan, K., Shimokawa, H., & Sadoshima, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci143173 · Cited by 59
The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
Nguyen‐Lefebvre, A. T., Selzner, N., Wrana, J. L., & Bhat, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002284rr · Cited by 58
Negrón‐Pérez, V. M., & Hansen, P. J. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox172 · Cited by 58
Sileo, P., Simonin, C., Melnyk, P., Chartier‐Harlin, M., & Cotelle, P. (2022) · Cells · doi:10.3390/cells11223631 · Cited by 57
Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
Watt, K. I., Harvey, K. F., & Gregorevic, P. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00942 · Cited by 57
Barthet, V. J. A., Brucoli, M., Ladds, M. J. G. W., Nössing, C., Kiourtis, C., Baudot, A. D., O’Prey, J., Zunino, B., Müller, M., May, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf9141 · Cited by 56
Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior
van Soldt, B. J., & Cardoso, W. V. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.371 · Cited by 54
Chloroquine Sensitizes GNAQ/11 -mutated Melanoma to MEK1/2 Inhibition
Truong, A., Yoo, J. H., Scherzer, M. T., Sanchez, J. M. S., Dale, K. J., Kinsey, C. G., Richards, J. R., Shin, D., Ghazi, P. C., Onken, M. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1675 · Cited by 54
Zhao, C., Zeng, C., Ye, S., Dai, X., He, Q., Yang, B., & Zhu, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.010 · Cited by 53
Targeting the Hippo signalling pathway for cancer treatment
Nakatani, K., Maehama, T., Nishio, M., Goto, H., Kato, W., Omori, H., Miyachi, Y., Togashi, H., Shimono, Y., & Suzuki, A. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw074 · Cited by 52
YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR
Pan, X., Wu, B., Fan, X., Xu, G., Ou, C., & Chen, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15902 · Cited by 52
Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches
Switon, K., Kotulska, K., Janusz-Kaminska, A., Zmorzyńska, J., & Jaworski, J. (2016) · IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology · doi:10.1002/iub.1579 · Cited by 39
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
Lu, X. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666190802135714 · Cited by 51
Hippo Pathway in Regulating Drug Resistance of Glioblastoma
Casati, G., Giunti, L., Iorio, A. L., Marturano, A., Galli, L., & Sardi, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413431 · Cited by 51
Ortega-Molina, A., Lebrero‐Fernández, C., Sanz, A., Calvo‐Rubio, M., Deleyto-Seldas, N., de Prado-Rivas, L., Plata-Gómez, A. B., Fernández-Florido, E., González‐García, P., Vivas, Y., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00635-x · Cited by 50
The Role of Hippo/YAP Signaling in Alveolar Repair and Pulmonary Fibrosis
Gokey, J. J., Patel, S. D., & Kropski, J. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.752316 · Cited by 49
The Hippo signal transduction network for exercise physiologists
Gabriel, B. M., Hamilton, D. L., Tremblay, A. M., & Wackerhage, H. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01076.2015 · Cited by 48
Role of mTORC1 in intestinal epithelial repair and tumorigenesis
Kaur, H., & Moreau, R. F. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03085-6 · Cited by 48
The biology of YAP in programmed cell death
Cheng, Y., Mao, M., & Lu, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00365-5 · Cited by 47
Asrani, K. V., Woo, J., Mendes, A. A. D. A., Schaffer, E. D., Vidotto, T., Villanueva, C. R., Feng, K., Oliveira, L., Murali, S., Liu, H. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34617-7 · Cited by 46
Mechanobiology of Autophagy: The Unexplored Side of Cancer
Hernández‐Cáceres, M. P., Munoz, L., Pradenas, J., Pena, F., Lagos, P., Aceitón, P., Owen, G. I., Morselli, E., Criollo, A., Ravasio, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.632956 · Cited by 46
The role of the Hippo pathway in autophagy in the heart
Maejima, Y., Zablocki, D., Nah, J., & Sadoshima, J. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac014 · Cited by 46
Aberrant activation of CYR61 enhancers in colorectal cancer development
Xie, L., Song, X., Lin, H. R., Chen, Z., Li, Q., Guo, T., Xu, T., Su, T., Xu, M., Chang, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1217-9 · Cited by 43
Yuan, T., Annamalai, K., Naik, S., Lupše, B., Geravandi, S., Pal, A., Dobrowolski, A., Ghawali, J., Ruhlandt, M., Gorrepati, K. D. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25145-x · Cited by 42
mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division
Bonucci, M., Kuperwasser, N., Barbe, S., Koka, V., de Villeneuve, D., Zhang, C., Srivastava, N., Jia, X., Stokes, M. P., Bienaimé, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16978-z · Cited by 41
Self-citationmTOR Signaling Components in Tumor Mechanobiology
Gargalionis, A. N., Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031825 · Cited by 41
Liao, Z., Zhang, X., Song, C., Lin, W., Cheng, Y., Xie, Z., Chen, S., Nie, Y., Li, A., Zhang, H., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02841-y · Cited by 40
Vučetić, M., Daher, B., Cassim, S., Meira, W., & Pouysségur, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02994-w · Cited by 40
A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo
Hernandez, J. O. R., Wang, X., Segoviano, M. V., López-Marfil, M., Sobral-Reyes, M. F., Moran-Horowich, A., Sundberg, M., Lopez-Cantu, D. O., Probst, C. K., Ruiz‐Esparza, G. U., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26596-y · Cited by 40
Self-citationPhosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas
Liu, M., Lin, Y., Zhang, X.-C., Tan, Y., Yao, Y., Tan, J., Zhang, X., Cui, Y., Liu, X., Wang, Y., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.70 · Cited by 39
Liu, Y., He, J., Li, B., Meng, Y., Wang, H., Tan, L., Liu, M., Lv, X., Lv, H., Zhang, X., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12834 · Cited by 39
Zhuang, Q., Li, F., Liu, J., Wang, H., Tian, Y., Zhang, Z., Wang, F., Zhao, Z., Chen, J., & Wu, H. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00503-3 · Cited by 39
The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
Mo, J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.2.199 · Cited by 39
Pei, T., Huang, X. H., Long, Y., Duan, C., Liu, T., Li, Y., & Huang, W. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.04.012 · Cited by 38
MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
Seo, J., Kim, M. H., Hong, H., Cho, H., Park, S., Kim, S. K., & Kim, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1339 · Cited by 37
Shen, Y., Goncharov, D. A., Pena, A. Z., Baust, J., Barragan, A. C., Ray, A., Rode, A., Bachman, T. N., Chang, B., Jiang, L., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abn2743 · Cited by 36
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Hong, D., & Iakoucheva, L. M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02356-y · Cited by 36
A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis
Jerić, I., Maurer, G., Cavallo, A. L., Raguz, J., Desideri, E., Tarkowski, B., Parrini, M., Fischer, I., Zatloukal, K., & Baccarini, M. (2016) · Nature Communications · doi:10.1038/ncomms13781 · Cited by 35
Metadata
- Authors
- Liang, N., Zhang, C., Dill, P., Panasyuk, G., Pion, D., Koka, V., Gallazzini, M., Olson, E. N., Lam, H., Henske, E. P., Dong, Z., Apte, U., Pallet, N., Johnson, R. L., Terzi, F., Kwiatkowski, D. J., Scoazec, J.-Y., Martignoni, G., & Pende, M.
- Affiliations
- Inserm (FR)
- The University of Texas Southwestern Medical Center (US)
- Brigham and Women's Hospital (US)
- Charlie Norwood VA Medical Center (US)
- University of Kansas Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Hospices Civils de Lyon (FR)
- University of Verona (IT)
- Corresponding author
- Pende, Mario
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-10-06
- Volume
- 211
- Issue
- 11
- Pages
- 2249-2263
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4203941
- OpenAlex
- W2111900780
- Cited by
- 205
- References
- 122
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 23 · 2021: 24 · 2020: 23 · 2019: 24 · 2018: 19 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 1
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Association pour la Recherche sur le Cancer
- Institut National de la Santé et de la Recherche Médicale
- China Scholarship Council
- Institut National Du Cancer
- National Cancer Institute (P01CA120964)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK096556)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- tuberous sclerosis complex, YAP, mTOR, autophagy, Hippo signaling pathway, PEComa, TSC1, TSC2, protein degradation, lysosomes, organ size control, therapeutic target, tumor growth control
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Verteporfin, YAP-Signaling Proteins, Animals, Autophagy, Cell Survival, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Kidney, Phosphoproteins, Porphyrins, Tuberous Sclerosis, Signal Transduction, Up-Regulation, Apoptosis, Angiomyolipoma, Mice, Knockout, Cell Cycle Proteins, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Cell Proliferation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.